Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Green Cross Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, and manufacturing of high-end parenteral nutrition and complex injection products. Founded in 1991, the company has established a dominant position in the domestic market for clinical nutrition, offering a wide range of amino acid injections, fat emulsions, and vitamin preparations. Its product portfolio is primarily designed for patients with metabolic stress, organ failure, or those requiring intensive nutritional support during perioperative care. The company operates advanced GMP-certified facilities and maintains a robust R&D pipeline focused on improving drug delivery systems and formulation stability for critical care medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Green Cross Drug Research & Development.